Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Antihypertensive Market 2018, Forecast to 2023

December 2018 | 131 pages | ID: G1ACE38216DEN
GlobalInfoResearch

Abstracts

Scope of the Report:


This report focuses on the Antihypertensive in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.
Antihypertensives are the drugs that are used to treat high blood pressure. This type of drug alleviate the complications of stroke and myocardial infarction.

The worldwide market for Antihypertensive is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Pfizer
• Novartis
• Sanofi
• Merck
• Boehringer Ingelheim
• Lupin
• Johnson & Johnson
• Astra Zeneca
• Daiichi Sankyo
• Ranbaxy

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Diuretics
• Angiotensin receptor blockers (ARBs)
• Angiotensin converting enzyme (ACE) inhibitors
• Beta blockers
• Alpha blockers
• Calcium channel blockers
• Renin inhibitors
• Vasodilators 

Market Segment by Applications, can be divided into

• Hosptial
• Clinic
• Home

There are 15 Chapters to deeply display the global Antihypertensive market.

Chapter 1, to describe Antihypertensive Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antihypertensive, with sales, revenue, and price of Antihypertensive, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Antihypertensive, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Antihypertensive market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Antihypertensive sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Antihypertensive Introduction
1.2 Market Analysis by Type
  1.2.1 Diuretics
  1.2.2 Angiotensin receptor blockers (ARBs)
  1.2.3 Angiotensin converting enzyme (ACE) inhibitors
  1.2.4 Beta blockers
  1.2.5 Alpha blockers
  1.2.6 Calcium channel blockers
  1.2.7 Renin inhibitors
  1.2.8 Vasodilators
1.3 Market Analysis by Applications
  1.3.1 Hosptial
  1.3.2 Clinic
  1.3.3 Home
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
    2.1.1.1 Pfizer Description
    2.1.1.2 Pfizer Headquarter, Main Business and Finance Overview
  2.1.2 Pfizer Antihypertensive Product Introduction
    2.1.2.1 Antihypertensive Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Antihypertensive Product Information
  2.1.3 Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global Pfizer Antihypertensive Market Share in 2017
2.2 Novartis
  2.2.1 Business Overview
    2.2.1.1 Novartis Description
    2.2.1.2 Novartis Headquarter, Main Business and Finance Overview
  2.2.2 Novartis Antihypertensive Product Introduction
    2.2.2.1 Antihypertensive Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Antihypertensive Product Information
  2.2.3 Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Novartis Antihypertensive Market Share in 2017
2.3 Sanofi
  2.3.1 Business Overview
    2.3.1.1 Sanofi Description
    2.3.1.2 Sanofi Headquarter, Main Business and Finance Overview
  2.3.2 Sanofi Antihypertensive Product Introduction
    2.3.2.1 Antihypertensive Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Antihypertensive Product Information
  2.3.3 Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Sanofi Antihypertensive Market Share in 2017
2.4 Merck
  2.4.1 Business Overview
    2.4.1.1 Merck Description
    2.4.1.2 Merck Headquarter, Main Business and Finance Overview
  2.4.2 Merck Antihypertensive Product Introduction
    2.4.2.1 Antihypertensive Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Antihypertensive Product Information
  2.4.3 Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Merck Antihypertensive Market Share in 2017
2.5 Boehringer Ingelheim
  2.5.1 Business Overview
    2.5.1.1 Boehringer Ingelheim Description
    2.5.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
  2.5.2 Boehringer Ingelheim Antihypertensive Product Introduction
    2.5.2.1 Antihypertensive Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Antihypertensive Product Information
  2.5.3 Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global Boehringer Ingelheim Antihypertensive Market Share in 2017
2.6 Lupin
  2.6.1 Business Overview
    2.6.1.1 Lupin Description
    2.6.1.2 Lupin Headquarter, Main Business and Finance Overview
  2.6.2 Lupin Antihypertensive Product Introduction
    2.6.2.1 Antihypertensive Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Antihypertensive Product Information
  2.6.3 Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Lupin Antihypertensive Market Share in 2017
2.7 Johnson & Johnson
  2.7.1 Business Overview
    2.7.1.1 Johnson & Johnson Description
    2.7.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
  2.7.2 Johnson & Johnson Antihypertensive Product Introduction
    2.7.2.1 Antihypertensive Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Antihypertensive Product Information
  2.7.3 Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Johnson & Johnson Antihypertensive Market Share in 2017
2.8 Astra Zeneca
  2.8.1 Business Overview
    2.8.1.1 Astra Zeneca Description
    2.8.1.2 Astra Zeneca Headquarter, Main Business and Finance Overview
  2.8.2 Astra Zeneca Antihypertensive Product Introduction
    2.8.2.1 Antihypertensive Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Antihypertensive Product Information
  2.8.3 Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global Astra Zeneca Antihypertensive Market Share in 2017
2.9 Daiichi Sankyo
  2.9.1 Business Overview
    2.9.1.1 Daiichi Sankyo Description
    2.9.1.2 Daiichi Sankyo Headquarter, Main Business and Finance Overview
  2.9.2 Daiichi Sankyo Antihypertensive Product Introduction
    2.9.2.1 Antihypertensive Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Antihypertensive Product Information
  2.9.3 Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.1 Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Global Daiichi Sankyo Antihypertensive Market Share in 2017
2.10 Ranbaxy
  2.10.1 Business Overview
    2.10.1.1 Ranbaxy Description
    2.10.1.2 Ranbaxy Headquarter, Main Business and Finance Overview
  2.10.2 Ranbaxy Antihypertensive Product Introduction
    2.10.2.1 Antihypertensive Production Bases, Sales Regions and Major Competitors
    2.10.2.2 Antihypertensive Product Information
  2.10.3 Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.1 Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 Global Ranbaxy Antihypertensive Market Share in 2017

3 GLOBAL ANTIHYPERTENSIVE MARKET COMPETITION, BY MANUFACTURER

3.1 Global Antihypertensive Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antihypertensive Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Antihypertensive Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Antihypertensive Manufacturer Market Share in 2017
  3.4.2 Top 5 Antihypertensive Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL ANTIHYPERTENSIVE MARKET ANALYSIS BY REGIONS

4.1 Global Antihypertensive Sales, Revenue and Market Share by Regions
  4.1.1 Global Antihypertensive Sales by Regions (2013-2018)
  4.1.2 Global Antihypertensive Revenue by Regions (2013-2018)
4.2 North America Antihypertensive Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Antihypertensive Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Antihypertensive Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Antihypertensive Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Antihypertensive Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ANTIHYPERTENSIVE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Antihypertensive Sales, Revenue and Market Share by Countries
  5.1.1 North America Antihypertensive Sales by Countries (2013-2018)
  5.1.2 North America Antihypertensive Revenue by Countries (2013-2018)
  5.1.3 United States Antihypertensive Sales and Growth Rate (2013-2018)
  5.1.4 Canada Antihypertensive Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Antihypertensive Sales and Growth Rate (2013-2018)
5.2 North America Antihypertensive Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Antihypertensive Sales by Manufacturers (2016-2017)
  5.2.2 North America Antihypertensive Revenue by Manufacturers (2016-2017)
5.3 North America Antihypertensive Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Antihypertensive Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Antihypertensive Revenue and Revenue Share by Type (2013-2018)
5.4 North America Antihypertensive Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Antihypertensive Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Antihypertensive Revenue and Revenue Share by Application (2013-2018)

6 EUROPE ANTIHYPERTENSIVE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Antihypertensive Sales, Revenue and Market Share by Countries
  6.1.1 Europe Antihypertensive Sales by Countries (2013-2018)
  6.1.2 Europe Antihypertensive Revenue by Countries (2013-2018)
  6.1.3 Germany Antihypertensive Sales and Growth Rate (2013-2018)
  6.1.4 UK Antihypertensive Sales and Growth Rate (2013-2018)
  6.1.5 France Antihypertensive Sales and Growth Rate (2013-2018)
  6.1.6 Russia Antihypertensive Sales and Growth Rate (2013-2018)
  6.1.7 Italy Antihypertensive Sales and Growth Rate (2013-2018)
6.2 Europe Antihypertensive Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Antihypertensive Sales by Manufacturers (2016-2017)
  6.2.2 Europe Antihypertensive Revenue by Manufacturers (2016-2017)
6.3 Europe Antihypertensive Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Antihypertensive Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Antihypertensive Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Antihypertensive Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Antihypertensive Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Antihypertensive Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC ANTIHYPERTENSIVE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Antihypertensive Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Antihypertensive Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Antihypertensive Revenue by Countries (2013-2018)
  7.1.3 China Antihypertensive Sales and Growth Rate (2013-2018)
  7.1.4 Japan Antihypertensive Sales and Growth Rate (2013-2018)
  7.1.5 Korea Antihypertensive Sales and Growth Rate (2013-2018)
  7.1.6 India Antihypertensive Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Antihypertensive Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Antihypertensive Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Antihypertensive Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Antihypertensive Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Antihypertensive Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Antihypertensive Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Antihypertensive Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Antihypertensive Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Antihypertensive Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Antihypertensive Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA ANTIHYPERTENSIVE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Antihypertensive Sales, Revenue and Market Share by Countries
  8.1.1 South America Antihypertensive Sales by Countries (2013-2018)
  8.1.2 South America Antihypertensive Revenue by Countries (2013-2018)
  8.1.3 Brazil Antihypertensive Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Antihypertensive Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Antihypertensive Sales and Growth Rate (2013-2018)
8.2 South America Antihypertensive Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Antihypertensive Sales by Manufacturers (2016-2017)
  8.2.2 South America Antihypertensive Revenue by Manufacturers (2016-2017)
8.3 South America Antihypertensive Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Antihypertensive Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Antihypertensive Revenue and Revenue Share by Type (2013-2018)
8.4 South America Antihypertensive Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Antihypertensive Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Antihypertensive Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA ANTIHYPERTENSIVE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Antihypertensive Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Antihypertensive Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Antihypertensive Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Antihypertensive Sales and Growth Rate (2013-2018)
  9.1.4 UAE Antihypertensive Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Antihypertensive Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Antihypertensive Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Antihypertensive Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Antihypertensive Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Antihypertensive Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Antihypertensive Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Antihypertensive Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Antihypertensive Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Antihypertensive Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Antihypertensive Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Antihypertensive Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Antihypertensive Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL ANTIHYPERTENSIVE MARKET SEGMENT BY TYPE

10.1 Global Antihypertensive Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Antihypertensive Sales and Market Share by Type (2013-2018)
  10.1.2 Global Antihypertensive Revenue and Market Share by Type (2013-2018)
10.2 Diuretics Sales Growth and Price
  10.2.1 Global Diuretics Sales Growth (2013-2018)
  10.2.2 Global Diuretics Price (2013-2018)
10.3 Angiotensin receptor blockers (ARBs) Sales Growth and Price
  10.3.1 Global Angiotensin receptor blockers (ARBs) Sales Growth (2013-2018)
  10.3.2 Global Angiotensin receptor blockers (ARBs) Price (2013-2018)
10.4 Angiotensin converting enzyme (ACE) inhibitors Sales Growth and Price
  10.4.1 Global Angiotensin converting enzyme (ACE) inhibitors Sales Growth (2013-2018)
  10.4.2 Global Angiotensin converting enzyme (ACE) inhibitors Price (2013-2018)
10.5 Beta blockers Sales Growth and Price
  10.5.1 Global Beta blockers Sales Growth (2013-2018)
  10.5.2 Global Beta blockers Price (2013-2018)
10.6 Alpha blockers Sales Growth and Price
  10.6.1 Global Alpha blockers Sales Growth (2013-2018)
  10.6.2 Global Alpha blockers Price (2013-2018)
10.7 Calcium channel blockers Sales Growth and Price
  10.7.1 Global Calcium channel blockers Sales Growth (2013-2018)
  10.7.2 Global Calcium channel blockers Price (2013-2018)
10.8 Renin inhibitors Sales Growth and Price
  10.8.1 Global Renin inhibitors Sales Growth (2013-2018)
  10.8.2 Global Renin inhibitors Price (2013-2018)
10.9 Vasodilators Sales Growth and Price
  10.9.1 Global Vasodilators Sales Growth (2013-2018)
  10.9.2 Global Vasodilators Price (2013-2018)

11 GLOBAL ANTIHYPERTENSIVE MARKET SEGMENT BY APPLICATION

11.1 Global Antihypertensive Sales Market Share by Application (2013-2018)
11.2 Hosptial Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Home Sales Growth (2013-2018)

12 ANTIHYPERTENSIVE MARKET FORECAST (2018-2023)

12.1 Global Antihypertensive Sales, Revenue and Growth Rate (2018-2023)
12.2 Antihypertensive Market Forecast by Regions (2018-2023)
  12.2.1 North America Antihypertensive Market Forecast (2018-2023)
  12.2.2 Europe Antihypertensive Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Antihypertensive Market Forecast (2018-2023)
  12.2.4 South America Antihypertensive Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Antihypertensive Market Forecast (2018-2023)
12.3 Antihypertensive Market Forecast by Type (2018-2023)
  12.3.1 Global Antihypertensive Sales Forecast by Type (2018-2023)
  12.3.2 Global Antihypertensive Market Share Forecast by Type (2018-2023)
12.4 Antihypertensive Market Forecast by Application (2018-2023)
  12.4.1 Global Antihypertensive Sales Forecast by Application (2018-2023)
  12.4.2 Global Antihypertensive Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Antihypertensive Picture
Table Product Specifications of Antihypertensive
Figure Global Antihypertensive CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Antihypertensive CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Antihypertensive by Types in 2017
Figure Diuretics Picture
Table Major Manufacturers of Diuretics
Figure Angiotensin receptor blockers (ARBs) Picture
Table Major Manufacturers of Angiotensin receptor blockers (ARBs)
Figure Angiotensin converting enzyme (ACE) inhibitors Picture
Table Major Manufacturers of Angiotensin converting enzyme (ACE) inhibitors
Figure Beta blockers Picture
Table Major Manufacturers of Beta blockers
Figure Alpha blockers Picture
Table Major Manufacturers of Alpha blockers
Figure Calcium channel blockers Picture
Table Major Manufacturers of Calcium channel blockers
Figure Renin inhibitors Picture
Table Major Manufacturers of Renin inhibitors
Figure Vasodilators Picture
Table Major Manufacturers of Vasodilators
Figure Antihypertensive Sales Market Share by Applications in 2017
Figure Hosptial Picture
Figure Clinic Picture
Figure Home Picture
Figure United States Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure France Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure UK Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure China Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure India Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Antihypertensive Production Bases, Sales Regions and Major Competitors
Table Pfizer Antihypertensive Product
Table Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Antihypertensive Sales Market Share in 2017
Figure Global Pfizer Antihypertensive Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Antihypertensive Production Bases, Sales Regions and Major Competitors
Table Novartis Antihypertensive Product
Table Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Antihypertensive Sales Market Share in 2017
Figure Global Novartis Antihypertensive Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Antihypertensive Production Bases, Sales Regions and Major Competitors
Table Sanofi Antihypertensive Product
Table Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Antihypertensive Sales Market Share in 2017
Figure Global Sanofi Antihypertensive Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Antihypertensive Production Bases, Sales Regions and Major Competitors
Table Merck Antihypertensive Product
Table Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Antihypertensive Sales Market Share in 2017
Figure Global Merck Antihypertensive Revenue Market Share in 2017
Table Boehringer Ingelheim Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim Antihypertensive Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim Antihypertensive Product
Table Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim Antihypertensive Sales Market Share in 2017
Figure Global Boehringer Ingelheim Antihypertensive Revenue Market Share in 2017
Table Lupin Headquarter, Established, Main Business and Finance Overview (2017)
Table Lupin Antihypertensive Production Bases, Sales Regions and Major Competitors
Table Lupin Antihypertensive Product
Table Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Lupin Antihypertensive Sales Market Share in 2017
Figure Global Lupin Antihypertensive Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Antihypertensive Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Antihypertensive Product
Table Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Antihypertensive Sales Market Share in 2017
Figure Global Johnson & Johnson Antihypertensive Revenue Market Share in 2017
Table Astra Zeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table Astra Zeneca Antihypertensive Production Bases, Sales Regions and Major Competitors
Table Astra Zeneca Antihypertensive Product
Table Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Astra Zeneca Antihypertensive Sales Market Share in 2017
Figure Global Astra Zeneca Antihypertensive Revenue Market Share in 2017
Table Daiichi Sankyo Headquarter, Established, Main Business and Finance Overview (2017)
Table Daiichi Sankyo Antihypertensive Production Bases, Sales Regions and Major Competitors
Table Daiichi Sankyo Antihypertensive Product
Table Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Daiichi Sankyo Antihypertensive Sales Market Share in 2017
Figure Global Daiichi Sankyo Antihypertensive Revenue Market Share in 2017
Table Ranbaxy Headquarter, Established, Main Business and Finance Overview (2017)
Table Ranbaxy Antihypertensive Production Bases, Sales Regions and Major Competitors
Table Ranbaxy Antihypertensive Product
Table Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ranbaxy Antihypertensive Sales Market Share in 2017
Figure Global Ranbaxy Antihypertensive Revenue Market Share in 2017
Table Global Antihypertensive Sales by Manufacturer (2016-2017)
Figure Global Antihypertensive Sales Market Share by Manufacturer in 2016
Figure Global Antihypertensive Sales Market Share by Manufacturer in 2017
Table Global Antihypertensive Revenue by Manufacturer (2016-2017)
Figure Global Antihypertensive Revenue Market Share by Manufacturer in 2016
Figure Global Antihypertensive Revenue Market Share by Manufacturer in 2017
Table Global Antihypertensive Price by Manufacturer (2016-2017)
Figure Top 3 Antihypertensive Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Antihypertensive Manufacturer (Revenue) Market Share in 2017
Figure Global Antihypertensive Sales and Growth Rate (2013-2018)
Figure Global Antihypertensive Revenue and Growth Rate (2013-2018)
Table Global Antihypertensive Sales by Regions (2013-2018)
Table Global Antihypertensive Sales Market Share by Regions (2013-2018)
Table Global Antihypertensive Revenue by Regions (2013-2018)
Figure Global Antihypertensive Revenue Market Share by Regions in 2013
Figure Global Antihypertensive Revenue Market Share by Regions in 2017
Figure North America Antihypertensive Sales and Growth Rate (2013-2018)
Figure North America Antihypertensive Revenue and Growth Rate (2013-2018)
Figure Europe Antihypertensive Sales and Growth Rate (2013-2018)
Figure Europe Antihypertensive Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Antihypertensive Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antihypertensive Revenue and Growth Rate (2013-2018)
Figure South America Antihypertensive Sales and Growth Rate (2013-2018)
Figure South America Antihypertensive Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Antihypertensive Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antihypertensive Revenue and Growth Rate (2013-2018)
Figure North America Antihypertensive Revenue and Growth Rate (2013-2018)
Table North America Antihypertensive Sales by Countries (2013-2018)
Table North America Antihypertensive Sales Market Share by Countries (2013-2018)
Figure North America Antihypertensive Sales Market Share by Countries in 2013
Figure North America Antihypertensive Sales Market Share by Countries in 2017
Table North America Antihypertensive Revenue by Countries (2013-2018)
Table North America Antihypertensive Revenue Market Share by Countries (2013-2018)
Figure North America Antihypertensive Revenue Market Share by Countries in 2013
Figure North America Antihypertensive Revenue Market Share by Countries in 2017
Figure United States Antihypertensive Sales and Growth Rate (2013-2018)
Figure Canada Antihypertensive Sales and Growth Rate (2013-2018)
Figure Mexico Antihypertensive Sales and Growth Rate (2013-2018)
Table North America Antihypertensive Sales by Manufacturer (2016-2017)
Figure North America Antihypertensive Sales Market Share by Manufacturer in 2016
Figure North America Antihypertensive Sales Market Share by Manufacturer in 2017
Table North America Antihypertensive Revenue by Manufacturer (2016-2017)
Figure North America Antihypertensive Revenue Market Share by Manufacturer in 2016
Figure North America Antihypertensive Revenue Market Share by Manufacturer in 2017
Table North America Antihypertensive Sales by Type (2013-2018)
Table North America Antihypertensive Sales Share by Type (2013-2018)
Table North America Antihypertensive Revenue by Type (2013-2018)
Table North America Antihypertensive Revenue Share by Type (2013-2018)
Table North America Antihypertensive Sales by Application (2013-2018)
Table North America Antihypertensive Sales Share by Application (2013-2018)
Table North America Antihypertensive Revenue by Application (2013-2018)
Table North America Antihypertensive Revenue Share by Application (2013-2018)
Figure Europe Antihypertensive Revenue and Growth Rate (2013-2018)
Table Europe Antihypertensive Sales by Countries (2013-2018)
Table Europe Antihypertensive Sales Market Share by Countries (2013-2018)
Table Europe Antihypertensive Revenue by Countries (2013-2018)
Figure Europe Antihypertensive Revenue Market Share by Countries in 2016
Figure Europe Antihypertensive Revenue Market Share by Countries in 2017
Figure Germany Antihypertensive Sales and Growth Rate (2013-2018)
Figure UK Antihypertensive Sales and Growth Rate (2013-2018)
Figure France Antihypertensive Sales and Growth Rate (2013-2018)
Figure Russia Antihypertensive Sales and Growth Rate (2013-2018)
Figure Italy Antihypertensive Sales and Growth Rate (2013-2018)
Table Europe Antihypertensive Sales by Manufacturer (2016-2017)
Figure Europe Antihypertensive Sales Market Share by Manufacturer in 2016
Figure Europe Antihypertensive Sales Market Share by Manufacturer in 2017
Table Europe Antihypertensive Revenue by Manufacturer (2016-2017)
Figure Europe Antihypertensive Revenue Market Share by Manufacturer in 2016
Figure Europe Antihypertensive Revenue Market Share by Manufacturer in 2017
Table Europe Antihypertensive Sales by Type (2013-2018)
Table Europe Antihypertensive Sales Share by Type (2013-2018)
Table Europe Antihypertensive Revenue by Type (2013-2018)
Table Europe Antihypertensive Revenue Share by Type (2013-2018)
Table Europe Antihypertensive Sales by Application (2013-2018)
Table Europe Antihypertensive Sales Share by Application (2013-2018)
Table Europe Antihypertensive Revenue by Application (2013-2018)
Table Europe Antihypertensive Revenue Share by Application (2013-2018)
Figure Asia-Pacific Antihypertensive Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Antihypertensive Sales by Countries (2013-2018)
Table Asia-Pacific Antihypertensive Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Antihypertensive Sales Market Share by Countries 2017
Table Asia-Pacific Antihypertensive Revenue by Countries (2013-2018)
Figure Asia-Pacific Antihypertensive Revenue Market Share by Countries 2017
Figure China Antihypertensive Sales and Growth Rate (2013-2018)
Figure Japan Antihypertensive Sales and Growth Rate (2013-2018)
Figure Korea Antihypertensive Sales and Growth Rate (2013-2018)
Figure India Antihypertensive Sales and Growth Rate (2013-2018)
Figure Southeast Asia Antihypertensive Sales and Growth Rate (2013-2018)
Table Asia-Pacific Antihypertensive Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Antihypertensive Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Antihypertensive Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Antihypertensive Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Antihypertensive Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Antihypertensive Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Antihypertensive Sales by Type (2013-2018)
Table Asia-Pacific Antihypertensive Sales Share by Type (2013-2018)
Table Asia-Pacific Antihypertensive Revenue by Type (2013-2018)
Table Asia-Pacific Antihypertensive Revenue Share by Type (2013-2018)
Table Asia-Pacific Antihypertensive Sales by Application (2013-2018)
Table Asia-Pacific Antihypertensive Sales Share by Application (2013-2018)
Table Asia-Pacific Antihypertensive Revenue by Application (2013-2018)
Table Asia-Pacific Antihypertensive Revenue Share by Application (2013-2018)
Figure South America Antihypertensive Revenue and Growth Rate (2013-2018)
Table South America Antihypertensive Sales by Countries (2013-2018)
Table South America Antihypertensive Sales Market Share by Countries (2013-2018)
Figure South America Antihypertensive Sales Market Share by Countries in 2017
Table South America Antihypertensive Revenue by Countries (2013-2018)
Table South America Antihypertensive Revenue Market Share by Countries (2013-2018)
Figure South America Antihypertensive Revenue Market Share by Countries in 2017
Figure Brazil Antihypertensive Sales and Growth Rate (2013-2018)
Figure Argentina Antihypertensive Sales and Growth Rate (2013-2018)
Figure Colombia Antihypertensive Sales and Growth Rate (2013-2018)
Table South America Antihypertensive Sales by Manufacturer (2016-2017)
Figure South America Antihypertensive Sales Market Share by Manufacturer in 2016
Figure South America Antihypertensive Sales Market Share by Manufacturer in 2017
Table South America Antihypertensive Revenue by Manufacturer (2016-2017)
Figure South America Antihypertensive Revenue Market Share by Manufacturer in 2016
Figure South America Antihypertensive Revenue Market Share by Manufacturer in 2017
Table South America Antihypertensive Sales by Type (2013-2018)
Table South America Antihypertensive Sales Share by Type (2013-2018)
Table South America Antihypertensive Revenue by Type (2013-2018)
Table South America Antihypertensive Revenue Share by Type (2013-2018)
Table South America Antihypertensive Sales by Application (2013-2018)
Table South America Antihypertensive Sales Share by Application (2013-2018)
Table South America Antihypertensive Revenue by Application (2013-2018)
Table South America Antihypertensive Revenue Share by Application (2013-2018)
Figure Middle East and Africa Antihypertensive Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Antihypertensive Sales by Countries (2013-2018)
Table Middle East and Africa Antihypertensive Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Antihypertensive Sales Market Share by Countries in 2017
Table Middle East and Africa Antihypertensive Revenue by Countries (2013-2018)
Table Middle East and Africa Antihypertensive Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antihypertensive Revenue Market Share by Countries in 2013
Figure Middle East and Africa Antihypertensive Revenue Market Share by Countries in 2017
Figure Saudi Arabia Antihypertensive Sales and Growth Rate (2013-2018)
Figure UAE Antihypertensive Sales and Growth Rate (2013-2018)
Figure Egypt Antihypertensive Sales and Growth Rate (2013-2018)
Figure Nigeria Antihypertensive Sales and Growth Rate (2013-2018)
Figure South Africa Antihypertensive Sales and Growth Rate (2013-2018)
Table Middle East and Africa Antihypertensive Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Antihypertensive Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Antihypertensive Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Antihypertensive Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Antihypertensive Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Antihypertensive Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Antihypertensive Sales by Type (2013-2018)
Table Middle East and Africa Antihypertensive Sales Share by Type (2013-2018)
Table Middle East and Africa Antihypertensive Revenue by Type (2013-2018)
Table Middle East and Africa Antihypertensive Revenue Share by Type (2013-2018)
Table Middle East and Africa Antihypertensive Sales by Application (2013-2018)
Table Middle East and Africa Antihypertensive Sales Share by Application (2013-2018)
Table Middle East and Africa Antihypertensive Revenue by Application (2013-2018)
Table Middle East and Africa Antihypertensive Revenue Share by Application (2013-2018)
Table Global Antihypertensive Sales by Type (2013-2018)
Table Global Antihypertensive Sales Share by Type (2013-2018)
Table Global Antihypertensive Revenue by Type (2013-2018)
Table Global Antihypertensive Revenue Share by Type (2013-2018)
Figure Global Diuretics Sales Growth (2013-2018)
Figure Global Diuretics Price (2013-2018)
Figure Global Angiotensin receptor blockers (ARBs) Sales Growth (2013-2018)
Figure Global Angiotensin receptor blockers (ARBs) Price (2013-2018)
Figure Global Angiotensin converting enzyme (ACE) inhibitors Sales Growth (2013-2018)
Figure Global Angiotensin converting enzyme (ACE) inhibitors Price (2013-2018)
Figure Global Beta blockers Sales Growth (2013-2018)
Figure Global Beta blockers Price (2013-2018)
Figure Global Alpha blockers Sales Growth (2013-2018)
Figure Global Alpha blockers Price (2013-2018)
Figure Global Calcium channel blockers Sales Growth (2013-2018)
Figure Global Calcium channel blockers Price (2013-2018)
Figure Global Renin inhibitors Sales Growth (2013-2018)
Figure Global Renin inhibitors Price (2013-2018)
Figure Global Vasodilators Sales Growth (2013-2018)
Figure Global Vasodilators Price (2013-2018)
Table Global Antihypertensive Sales by Application (2013-2018)
Table Global Antihypertensive Sales Share by Application (2013-2018)
Figure Global Hosptial Sales Growth (2013-2018)
Figure Global Clinic Sales Growth (2013-2018)
Figure Global Home Sales Growth (2013-2018)
Figure Global Antihypertensive Sales, Revenue and Growth Rate (2018-2023)
Table Global Antihypertensive Sales Forecast by Regions (2018-2023)
Table Global Antihypertensive Market Share Forecast by Regions (2018-2023)
Figure North America Sales Antihypertensive Market Forecast (2018-2023)
Figure Europe Sales Antihypertensive Market Forecast (2018-2023)
Figure Asia-Pacific Sales Antihypertensive Market Forecast (2018-2023)
Figure South America Sales Antihypertensive Market Forecast (2018-2023)
Figure Middle East and Africa Sales Antihypertensive Market Forecast (2018-2023)
Table Global Antihypertensive Sales Forecast by Type (2018-2023)
Table Global Antihypertensive Market Share Forecast by Type (2018-2023)
Table Global Antihypertensive Sales Forecast by Application (2018-2023)
Table Global Antihypertensive Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List